Filing Details
PRECISION BIOSCIENCES INC (NASDAQ:DTIL) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on November 03, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:DTIL
PRECISION BIOSCIENCES INC (DTIL) Files Quarterly Report for Q0
PRECISION BIOSCIENCES INC (NASDAQ:DTIL) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on November 03, 2026.
At publication ·
What changed
PRECISION BIOSCIENCES INC (NASDAQ:DTIL) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Precision Biosciences (NASDAQ: DTIL) filed its quarterly 10-Q report with the SEC on November 3, 2026.
- The company's stock trades at $6.95 with a market capitalization of $65.0 million.
- The quarterly report contains unaudited financial statements and management commentary on business performance and emerging trends.
Market Context
PRECISION BIOSCIENCES INC's stock currently trades at $6.95 with a market capitalization of $65.0M.
The 10-Q provides PRECISION BIOSCIENCES INC's quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for PRECISION BIOSCIENCES INC are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View DTIL Stock Page
Frequently Asked Questions
Where can I read DTIL's SEC filings?
Browse all filings on our DTIL SEC filings page.
What types of SEC filings does PRECISION BIOSCIENCES INC file?
Public companies like PRECISION BIOSCIENCES INC file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.